Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study

PURPOSE: Capecitabine, an oral fluorouracil (5-FU) derivative, has replaced 5-FU in many chemotherapy regimens used in various GI tract cancers. The experience with capecitabine in nasopharyngeal carcinoma (NPC) is limited. PATIENTS AND METHODS: We report on eight patients with locally advanced NPC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Glob Oncol
Glavni autori: Dada, Reyad, El Sayed, Mohamed, Zekri, Jamal
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2016
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646894/
https://ncbi.nlm.nih.gov/pubmed/29094083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.2016.006924
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items